Portfolio Holdings Detail for ISIN IE00BYZK4776
Stock Name / FundiShares Healthcare Innovation UCITS ETF USD (Acc)
IssuerBlackrock
Entity holding fund iShares IV Public Limited Company
Entity TypeUmbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300ZP07LMR36K1T02
ETF TickerDRDR(GBX) LSE
ETF Ticker2B78(EUR) F
ETF Ticker2B78.DE(EUR) CXE
ETF TickerDRDR.LS(GBX) CXE
ETF TickerHEAL.AS(EUR) CXE
ETF TickerHEAL.LS(USD) CXE
ETF TickerHEALz(USD) CXE
ETF TickerHEAL(EUR) ETF Plus
ETF TickerDRDR.L(GBP) LSE

Holdings detail for ITCI

Stock NameIntracellular Th
TickerITCI(USD) NASDAQ
TYPECommon Stock
CountryUSA
ISINUS46116X1019
LEI5299002U2KGF193IJA20

Show aggregate ITCI holdings

News associated with ITCI

StockNews.com Initiates Coverage on Intra-Cellular Therapies (NASDAQ:ITCI)
Investment analysts at StockNews.com started coverage on shares of Intra-Cellular Therapies (NASDAQ:ITCI – Get Free Report) in a research report issued to clients and investors on Wednesday. The firm set a “hold” rating on the biopharmaceutical company’s stock. Other equities analysts have also issued research reports about the stock. Piper Sandler reissued a “neutral” rating […] - 2025-05-09 05:14:56
MetLife Investment Management LLC Sells 145 Shares of Intra-Cellular Therapies, Inc. (NASDAQ:ITCI)
MetLife Investment Management LLC trimmed its position in shares of Intra-Cellular Therapies, Inc. (NASDAQ:ITCI – Free Report) by 2.2% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 6,343 shares of the biopharmaceutical company’s stock after selling 145 shares during the period. MetLife […] - 2025-05-06 08:01:00
Intra-Cellular Therapies (NASDAQ:ITCI) Now Covered by Analysts at StockNews.com
StockNews.com started coverage on shares of Intra-Cellular Therapies (NASDAQ:ITCI – Free Report) in a research report report published on Tuesday morning. The firm issued a hold rating on the biopharmaceutical company’s stock. A number of other brokerages have also recently weighed in on ITCI. Cantor Fitzgerald reiterated a “neutral” rating and set a $132.00 price […] - 2025-04-30 07:44:58
Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) Shares Acquired by Mariner LLC
Mariner LLC lifted its stake in shares of Intra-Cellular Therapies, Inc. (NASDAQ:ITCI – Free Report) by 7.8% during the fourth quarter, Holdings Channel.com reports. The fund owned 10,497 shares of the biopharmaceutical company’s stock after purchasing an additional 758 shares during the period. Mariner LLC’s holdings in Intra-Cellular Therapies were worth $877,000 at the end […] - 2025-04-29 08:00:50
Sterling Capital Management LLC Has $139,000 Position in Intra-Cellular Therapies, Inc. (NASDAQ:ITCI)
Sterling Capital Management LLC decreased its holdings in shares of Intra-Cellular Therapies, Inc. (NASDAQ:ITCI – Free Report) by 11.1% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 1,663 shares of the biopharmaceutical company’s stock after selling 207 shares during the quarter. Sterling […] - 2025-04-22 08:16:58
Intra-Cellular Therapies (NASDAQ:ITCI) Earns Hold Rating from Analysts at StockNews.com
StockNews.com started coverage on shares of Intra-Cellular Therapies (NASDAQ:ITCI – Free Report) in a report published on Monday. The brokerage issued a hold rating on the biopharmaceutical company’s stock. Several other research analysts also recently commented on the company. Mizuho lowered Intra-Cellular Therapies from an “outperform” rating to a “neutral” rating and cut their price […] - 2025-04-22 05:48:50
Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) Position Decreased by Russell Investments Group Ltd.
Russell Investments Group Ltd. reduced its holdings in Intra-Cellular Therapies, Inc. (NASDAQ:ITCI – Free Report) by 39.4% during the fourth quarter, Holdings Channel reports. The firm owned 32,306 shares of the biopharmaceutical company’s stock after selling 21,017 shares during the period. Russell Investments Group Ltd.’s holdings in Intra-Cellular Therapies were worth $2,698,000 at the end […] - 2025-04-18 08:26:53
Envestnet Asset Management Inc. Sells 2,317 Shares of Intra-Cellular Therapies, Inc. (NASDAQ:ITCI)
Envestnet Asset Management Inc. cut its stake in Intra-Cellular Therapies, Inc. (NASDAQ:ITCI – Free Report) by 1.7% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 131,662 shares of the biopharmaceutical company’s stock after selling 2,317 shares during the period. Envestnet Asset […] - 2025-04-18 07:45:00
Legal & General Group Plc Sells 8,681 Shares of Intra-Cellular Therapies, Inc. (NASDAQ:ITCI)
Legal & General Group Plc cut its holdings in Intra-Cellular Therapies, Inc. (NASDAQ:ITCI – Free Report) by 5.5% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 149,161 shares of the biopharmaceutical company’s stock after selling 8,681 shares during […] - 2025-04-17 09:08:51
StockNews.com Initiates Coverage on Intra-Cellular Therapies (NASDAQ:ITCI)
Equities researchers at StockNews.com began coverage on shares of Intra-Cellular Therapies (NASDAQ:ITCI – Get Free Report) in a research note issued to investors on Sunday. The firm set a “hold” rating on the biopharmaceutical company’s stock. ITCI has been the subject of a number of other research reports. Mizuho downgraded shares of Intra-Cellular Therapies from […] - 2025-04-15 05:16:49
Cantor Fitzgerald Reiterates “Neutral” Rating for Intra-Cellular Therapies (NASDAQ:ITCI)
Intra-Cellular Therapies (NASDAQ:ITCI – Get Free Report)‘s stock had its “neutral” rating reaffirmed by research analysts at Cantor Fitzgerald in a research note issued to investors on Wednesday,Benzinga reports. They currently have a $132.00 price objective on the biopharmaceutical company’s stock. Cantor Fitzgerald’s price objective points to a potential upside of 0.10% from the company’s […] - 2025-04-04 05:56:51
Brokerages Set Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) Target Price at $106.08
Intra-Cellular Therapies, Inc. (NASDAQ:ITCI – Get Free Report) has been assigned an average recommendation of “Hold” from the fifteen ratings firms that are covering the stock, MarketBeat reports. Nine research analysts have rated the stock with a hold rating, five have issued a buy rating and one has issued a strong buy rating on the […] - 2025-04-02 06:09:06
Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) Shares Acquired by Vanguard Group Inc.
Vanguard Group Inc. increased its stake in shares of Intra-Cellular Therapies, Inc. (NASDAQ:ITCI – Free Report) by 1.0% during the 4th quarter, Holdings Channel reports. The fund owned 9,721,360 shares of the biopharmaceutical company’s stock after purchasing an additional 93,107 shares during the quarter. Vanguard Group Inc. owned approximately 0.09% of Intra-Cellular Therapies worth $811,928,000 […] - 2025-03-30 09:28:47
19,043 Shares in Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) Acquired by Proficio Capital Partners LLC
Proficio Capital Partners LLC purchased a new position in shares of Intra-Cellular Therapies, Inc. (NASDAQ:ITCI – Free Report) in the 4th quarter, Holdings Channel reports. The firm purchased 19,043 shares of the biopharmaceutical company’s stock, valued at approximately $1,590,000. A number of other institutional investors also recently bought and sold shares of ITCI. Wasatch Advisors […] - 2025-03-20 07:50:52
Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) Position Lowered by PNC Financial Services Group Inc.
PNC Financial Services Group Inc. decreased its stake in shares of Intra-Cellular Therapies, Inc. (NASDAQ:ITCI – Free Report) by 4.3% during the 4th quarter, HoldingsChannel.com reports. The firm owned 8,034 shares of the biopharmaceutical company’s stock after selling 357 shares during the quarter. PNC Financial Services Group Inc.’s holdings in Intra-Cellular Therapies were worth $671,000 […] - 2025-03-19 08:03:17
SCHA, ITCI, AFRM, EXEL: Large Outflows Detected at ETF
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the Schwab US Small-Cap ETF (Symbol: SCHA) where we have detected an approximate $550.8 million dollar outflow -- that's a 3.3% decrease week over week - 2025-03-17 14:52:32
M&T Bank Corp Purchases 138 Shares of Intra-Cellular Therapies, Inc. (NASDAQ:ITCI)
M&T Bank Corp grew its position in shares of Intra-Cellular Therapies, Inc. (NASDAQ:ITCI – Free Report) by 2.2% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 6,301 shares of the biopharmaceutical company’s stock after purchasing an additional 138 shares during the quarter. M&T […] - 2025-03-14 08:54:58
Assetmark Inc. Has $191,000 Holdings in Intra-Cellular Therapies, Inc. (NASDAQ:ITCI)
Assetmark Inc. cut its position in Intra-Cellular Therapies, Inc. (NASDAQ:ITCI – Free Report) by 7.8% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 2,284 shares of the biopharmaceutical company’s stock after selling 193 shares during the quarter. Assetmark Inc.’s holdings in Intra-Cellular Therapies […] - 2025-03-14 07:56:54
Intra-Cellular Therapies (NASDAQ:ITCI) Now Covered by StockNews.com
Investment analysts at StockNews.com started coverage on shares of Intra-Cellular Therapies (NASDAQ:ITCI – Get Free Report) in a report issued on Wednesday. The brokerage set a “hold” rating on the biopharmaceutical company’s stock. Several other analysts have also issued reports on ITCI. Mizuho lowered Intra-Cellular Therapies from an “outperform” rating to a “neutral” rating and […] - 2025-03-12 06:19:01
Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) Shares Bought by Charles Schwab Investment Management Inc.
Charles Schwab Investment Management Inc. raised its holdings in Intra-Cellular Therapies, Inc. (NASDAQ:ITCI – Free Report) by 0.2% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 906,646 shares of the biopharmaceutical company’s stock after acquiring an additional 1,737 shares during the […] - 2025-03-11 08:32:53
Jones Financial Companies Lllp Has $550,000 Position in Intra-Cellular Therapies, Inc. (NASDAQ:ITCI)
Jones Financial Companies Lllp raised its position in Intra-Cellular Therapies, Inc. (NASDAQ:ITCI – Free Report) by 71.6% in the 4th quarter, Holdings Channel.com reports. The firm owned 6,590 shares of the biopharmaceutical company’s stock after buying an additional 2,750 shares during the period. Jones Financial Companies Lllp’s holdings in Intra-Cellular Therapies were worth $550,000 at […] - 2025-03-11 07:44:50
Proficio Capital Partners LLC Purchases Shares of 19,043 Intra-Cellular Therapies, Inc. (NASDAQ:ITCI)
Proficio Capital Partners LLC purchased a new stake in Intra-Cellular Therapies, Inc. (NASDAQ:ITCI – Free Report) in the fourth quarter, according to its most recent Form 13F filing with the SEC. The institutional investor purchased 19,043 shares of the biopharmaceutical company’s stock, valued at approximately $1,590,000. A number of other institutional investors and hedge funds […] - 2025-03-07 09:26:52
Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) Shares Bought by New York State Common Retirement Fund
New York State Common Retirement Fund lifted its stake in shares of Intra-Cellular Therapies, Inc. (NASDAQ:ITCI – Free Report) by 7.2% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 76,563 shares of the biopharmaceutical company’s stock after purchasing an additional 5,162 shares during the […] - 2025-02-27 08:51:02
CIBC Asset Management Inc Purchases 150 Shares of Intra-Cellular Therapies, Inc. (NASDAQ:ITCI)
CIBC Asset Management Inc grew its stake in shares of Intra-Cellular Therapies, Inc. (NASDAQ:ITCI – Free Report) by 5.3% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 2,956 shares of the biopharmaceutical company’s stock after buying an additional 150 shares during the […] - 2025-02-26 08:52:53
Intra-Cellular Therapies (NASDAQ:ITCI) Coverage Initiated by Analysts at StockNews.com
Investment analysts at StockNews.com began coverage on shares of Intra-Cellular Therapies (NASDAQ:ITCI – Get Free Report) in a report issued on Monday. The firm set a “hold” rating on the biopharmaceutical company’s stock. A number of other brokerages have also weighed in on ITCI. Piper Sandler reaffirmed a “neutral” rating and issued a $132.00 target […] - 2025-02-24 07:14:57
Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) Shares Sold by Mirae Asset Global Investments Co. Ltd.
Mirae Asset Global Investments Co. Ltd. trimmed its holdings in Intra-Cellular Therapies, Inc. (NASDAQ:ITCI – Free Report) by 7.6% in the fourth quarter, HoldingsChannel.com reports. The firm owned 3,533 shares of the biopharmaceutical company’s stock after selling 289 shares during the quarter. Mirae Asset Global Investments Co. Ltd.’s holdings in Intra-Cellular Therapies were worth $300,000 […] - 2025-02-14 08:30:50
Wilmington Savings Fund Society FSB Acquires 740 Shares of Intra-Cellular Therapies, Inc. (NASDAQ:ITCI)
Wilmington Savings Fund Society FSB increased its holdings in shares of Intra-Cellular Therapies, Inc. (NASDAQ:ITCI – Free Report) by 55.7% in the fourth quarter, Holdings Channel.com reports. The firm owned 2,069 shares of the biopharmaceutical company’s stock after purchasing an additional 740 shares during the quarter. Wilmington Savings Fund Society FSB’s holdings in Intra-Cellular Therapies […] - 2025-02-13 08:52:56

iShares Healthcare Innovation UCITS ETF USD (Acc) ITCI holdings

DateNumber of ITCI Shares HeldBase Market Value of ITCI SharesLocal Market Value of ITCI SharesChange in ITCI Shares HeldChange in ITCI Base ValueCurrent Price per ITCI Share HeldPrevious Price per ITCI Share Held
2025-04-02 (Wednesday)121,905USD 16,075,612USD 16,075,6120USD 0 USD 131.87 USD 131.87
2025-04-01 (Tuesday)121,905USD 16,075,612ITCI holding decreased by -6096USD 16,075,6120USD -6,096 USD 131.87 USD 131.92
2025-03-31 (Monday)121,905ITCI holding decreased by -924USD 16,081,708ITCI holding decreased by -108382USD 16,081,708-924USD -108,382 USD 131.92 USD 131.81
2025-03-28 (Friday)122,829USD 16,190,090ITCI holding increased by 7369USD 16,190,0900USD 7,369 USD 131.81 USD 131.75
2025-03-27 (Thursday)122,829USD 16,182,721ITCI holding increased by 7370USD 16,182,7210USD 7,370 USD 131.75 USD 131.69
2025-03-26 (Wednesday)122,829USD 16,175,351ITCI holding decreased by -1228USD 16,175,3510USD -1,228 USD 131.69 USD 131.7
2025-03-25 (Tuesday)122,829USD 16,176,579USD 16,176,5790USD 0 USD 131.7 USD 131.7
2025-03-24 (Monday)122,829USD 16,176,579ITCI holding increased by 6141USD 16,176,5790USD 6,141 USD 131.7 USD 131.65
2025-03-21 (Friday)122,829ITCI holding decreased by -924USD 16,170,438ITCI holding decreased by -115457USD 16,170,438-924USD -115,457 USD 131.65 USD 131.6
2025-03-20 (Thursday)123,753USD 16,285,895ITCI holding increased by 8663USD 16,285,8950USD 8,663 USD 131.6 USD 131.53
2025-03-19 (Wednesday)123,753USD 16,277,232ITCI holding increased by 9900USD 16,277,2320USD 9,900 USD 131.53 USD 131.45
2025-03-18 (Tuesday)123,753USD 16,267,332USD 16,267,3320USD 0 USD 131.45 USD 131.45
2025-03-17 (Monday)123,753USD 16,267,332ITCI holding increased by 23513USD 16,267,3320USD 23,513 USD 131.45 USD 131.26
2025-03-14 (Friday)123,753USD 16,243,819ITCI holding decreased by -12375USD 16,243,8190USD -12,375 USD 131.26 USD 131.36
2025-03-13 (Thursday)123,753USD 16,256,194ITCI holding increased by 13613USD 16,256,1940USD 13,613 USD 131.36 USD 131.25
2025-03-12 (Wednesday)123,753ITCI holding decreased by -462USD 16,242,581ITCI holding decreased by -59396USD 16,242,581-462USD -59,396 USD 131.25 USD 131.24
2025-03-11 (Tuesday)124,215USD 16,301,977ITCI holding decreased by -1242USD 16,301,9770USD -1,242 USD 131.24 USD 131.25
2025-03-10 (Monday)124,215USD 16,303,219ITCI holding increased by 1242USD 16,303,2190USD 1,242 USD 131.25 USD 131.24
2025-03-07 (Friday)124,215USD 16,301,977ITCI holding decreased by -1242USD 16,301,9770USD -1,242 USD 131.24 USD 131.25
2025-03-06 (Thursday)124,215USD 16,303,219ITCI holding increased by 7453USD 16,303,2190USD 7,453 USD 131.25 USD 131.19
2025-03-05 (Wednesday)124,215USD 16,295,766ITCI holding decreased by -6211USD 16,295,7660USD -6,211 USD 131.19 USD 131.24
2025-03-04 (Tuesday)124,215USD 16,301,977ITCI holding decreased by -4968USD 16,301,9770USD -4,968 USD 131.24 USD 131.28
2025-03-03 (Monday)124,215USD 16,306,945ITCI holding increased by 382582USD 16,306,9450USD 382,582 USD 131.28 USD 128.2
2025-02-28 (Friday)124,215ITCI holding decreased by -462USD 15,924,363ITCI holding decreased by -65462USD 15,924,363-462USD -65,462 USD 128.2 USD 128.25
2025-02-27 (Thursday)124,677USD 15,989,825ITCI holding decreased by -26182USD 15,989,8250USD -26,182 USD 128.25 USD 128.46
2025-02-26 (Wednesday)124,677USD 16,016,007ITCI holding decreased by -14962USD 16,016,0070USD -14,962 USD 128.46 USD 128.58
2025-02-25 (Tuesday)124,677ITCI holding increased by 462USD 16,030,969ITCI holding increased by 60646USD 16,030,969462USD 60,646 USD 128.58 USD 128.57
2025-02-24 (Monday)124,215USD 15,970,323ITCI holding decreased by -3726USD 15,970,3230USD -3,726 USD 128.57 USD 128.6
2025-02-21 (Friday)124,215USD 15,974,049ITCI holding increased by 7453USD 15,974,0490USD 7,453 USD 128.6 USD 128.54
2025-02-20 (Thursday)124,215ITCI holding decreased by -462USD 15,966,596ITCI holding decreased by -66866USD 15,966,596-462USD -66,866 USD 128.54 USD 128.6
2025-02-19 (Wednesday)124,677ITCI holding increased by 924USD 16,033,462ITCI holding increased by 198028USD 16,033,462924USD 198,028 USD 128.6 USD 127.96
2025-02-18 (Tuesday)123,753ITCI holding increased by 462USD 15,835,434ITCI holding increased by 76378USD 15,835,434462USD 76,378 USD 127.96 USD 127.82
2025-02-17 (Monday)123,291USD 15,759,056USD 15,759,0560USD 0 USD 127.82 USD 127.82
2025-02-14 (Friday)123,291USD 15,759,056ITCI holding decreased by -29589USD 15,759,0560USD -29,589 USD 127.82 USD 128.06
2025-02-13 (Thursday)123,291USD 15,788,645ITCI holding increased by 11096USD 15,788,6450USD 11,096 USD 128.06 USD 127.97
2025-02-12 (Wednesday)123,291USD 15,777,549ITCI holding increased by 50549USD 15,777,5490USD 50,549 USD 127.97 USD 127.56
2025-02-11 (Tuesday)123,291USD 15,727,000ITCI holding increased by 54248USD 15,727,0000USD 54,248 USD 127.56 USD 127.12
2025-02-10 (Monday)123,291USD 15,672,752ITCI holding increased by 13562USD 15,672,7520USD 13,562 USD 127.12 USD 127.01
2025-02-07 (Friday)123,291USD 15,659,190ITCI holding decreased by -13562USD 15,659,1900USD -13,562 USD 127.01 USD 127.12
2025-02-06 (Thursday)123,291USD 15,672,752ITCI holding increased by 11096USD 15,672,7520USD 11,096 USD 127.12 USD 127.03
2025-02-05 (Wednesday)123,291USD 15,661,656ITCI holding increased by 16028USD 15,661,6560USD 16,028 USD 127.03 USD 126.9
2025-02-04 (Tuesday)123,291USD 15,645,628ITCI holding decreased by -35754USD 15,645,6280USD -35,754 USD 126.9 USD 127.19
2025-02-03 (Monday)123,291USD 15,681,382ITCI holding increased by 13562USD 15,681,3820USD 13,562 USD 127.19 USD 127.08
2025-01-31 (Friday)123,291USD 15,667,820ITCI holding increased by 9863USD 15,667,8200USD 9,863 USD 127.08 USD 127
2025-01-30 (Thursday)123,291USD 15,657,957ITCI holding decreased by -2466USD 15,657,9570USD -2,466 USD 127 USD 127.02
2025-01-29 (Wednesday)123,291USD 15,660,423ITCI holding increased by 2466USD 15,660,4230USD 2,466 USD 127.02 USD 127
2025-01-28 (Tuesday)123,291USD 15,657,957ITCI holding decreased by -25891USD 15,657,9570USD -25,891 USD 127 USD 127.21
2025-01-27 (Monday)123,291USD 15,683,848ITCI holding decreased by -17261USD 15,683,8480USD -17,261 USD 127.21 USD 127.35
2025-01-24 (Friday)123,291USD 15,701,109ITCI holding increased by 34522USD 15,701,1090USD 34,522 USD 127.35 USD 127.07
2025-01-23 (Thursday)123,291USD 15,666,587ITCI holding decreased by -9864USD 15,666,5870USD -9,864 USD 127.07 USD 127.15
2025-01-22 (Wednesday)123,291USD 15,676,451USD 15,676,451
2025-01-21 (Tuesday)123,753USD 15,654,755USD 15,654,755
2025-01-20 (Monday)123,753USD 15,617,629USD 15,617,629
2025-01-17 (Friday)123,753USD 15,617,629USD 15,617,629
2025-01-16 (Thursday)124,215USD 15,683,386USD 15,683,386
2025-01-15 (Wednesday)124,215USD 15,739,283USD 15,739,283
2025-01-14 (Tuesday)124,215USD 15,761,641USD 15,761,641
2025-01-13 (Monday)124,215USD 15,798,906USD 15,798,906
2025-01-10 (Friday)124,215USD 11,784,277USD 11,784,277
2025-01-09 (Thursday)124,215USD 10,255,190USD 10,255,190
2025-01-09 (Thursday)124,215USD 10,255,190USD 10,255,190
2025-01-09 (Thursday)124,215USD 10,255,190USD 10,255,190
2025-01-08 (Wednesday)124,215USD 10,255,190USD 10,255,190
2025-01-08 (Wednesday)124,215USD 10,255,190USD 10,255,190
2025-01-08 (Wednesday)124,215USD 10,255,190USD 10,255,190
2025-01-02 (Thursday)124,215USD 10,463,872ITCI holding increased by 94404USD 10,463,8720USD 94,404 USD 84.24 USD 83.48
2024-12-30 (Monday)124,215ITCI holding increased by 1112USD 10,369,468ITCI holding increased by 138378USD 10,369,4681,112USD 138,378 USD 83.48 USD 83.11
2024-12-10 (Tuesday)123,103USD 10,231,090ITCI holding decreased by -227741USD 10,231,0900USD -227,741 USD 83.11 USD 84.96
2024-12-09 (Monday)123,103USD 10,458,831ITCI holding increased by 50472USD 10,458,8310USD 50,472 USD 84.96 USD 84.55
2024-12-06 (Friday)123,103ITCI holding decreased by -454USD 10,408,359ITCI holding increased by 18451USD 10,408,359-454USD 18,451 USD 84.55 USD 84.09
2024-12-05 (Thursday)123,557USD 10,389,908ITCI holding decreased by -229816USD 10,389,9080USD -229,816 USD 84.09 USD 85.95
2024-12-04 (Wednesday)123,557ITCI holding decreased by -454USD 10,619,724ITCI holding increased by 40346USD 10,619,724-454USD 40,346 USD 85.95 USD 85.31
2024-12-03 (Tuesday)124,011ITCI holding decreased by -908USD 10,579,378ITCI holding decreased by -167404USD 10,579,378-908USD -167,404 USD 85.31 USD 86.03
2024-12-02 (Monday)124,919USD 10,746,782ITCI holding increased by 47470USD 10,746,7820USD 47,470 USD 86.03 USD 85.65
2024-11-29 (Friday)124,919USD 10,699,312ITCI holding decreased by -117424USD 10,699,3120USD -117,424 USD 85.65 USD 86.59
2024-11-28 (Thursday)124,919USD 10,816,736USD 10,816,7360USD 0 USD 86.59 USD 86.59
2024-11-27 (Wednesday)124,919USD 10,816,736ITCI holding increased by 19987USD 10,816,7360USD 19,987 USD 86.59 USD 86.43
2024-11-26 (Tuesday)124,919USD 10,796,749ITCI holding increased by 179883USD 10,796,7490USD 179,883 USD 86.43 USD 84.99
2024-11-25 (Monday)124,919USD 10,616,866ITCI holding decreased by -87443USD 10,616,8660USD -87,443 USD 84.99 USD 85.69
2024-11-22 (Friday)124,919ITCI holding increased by 972USD 10,704,309ITCI holding increased by 113038USD 10,704,309972USD 113,038 USD 85.69 USD 85.45
2024-11-21 (Thursday)123,947ITCI holding decreased by -452USD 10,591,271ITCI holding decreased by -62259USD 10,591,271-452USD -62,259 USD 85.45 USD 85.64
2024-11-20 (Wednesday)124,399ITCI holding decreased by -454USD 10,653,530ITCI holding increased by 247032USD 10,653,530-454USD 247,032 USD 85.64 USD 83.35
2024-11-19 (Tuesday)124,853ITCI holding decreased by -454USD 10,406,498ITCI holding increased by 72430USD 10,406,498-454USD 72,430 USD 83.35 USD 82.47
2024-11-18 (Monday)125,307ITCI holding decreased by -1804USD 10,334,068ITCI holding decreased by -913984USD 10,334,068-1,804USD -913,984 USD 82.47 USD 88.49
2024-11-12 (Tuesday)127,111ITCI holding decreased by -451USD 11,248,052ITCI holding decreased by -397083USD 11,248,052-451USD -397,083 USD 88.49 USD 91.29
2024-11-08 (Friday)127,562USD 11,645,135ITCI holding increased by 99498USD 11,645,1350USD 99,498 USD 91.29 USD 90.51
2024-11-07 (Thursday)127,562ITCI holding decreased by -451USD 11,545,637ITCI holding increased by 96154USD 11,545,637-451USD 96,154 USD 90.51 USD 89.44
2024-11-06 (Wednesday)128,013USD 11,449,483ITCI holding increased by 25603USD 11,449,4830USD 25,603 USD 89.44 USD 89.24
2024-11-05 (Tuesday)128,013ITCI holding decreased by -902USD 11,423,880ITCI holding increased by 315274USD 11,423,880-902USD 315,274 USD 89.24 USD 86.17
2024-11-04 (Monday)128,915USD 11,108,606ITCI holding decreased by -47698USD 11,108,6060USD -47,698 USD 86.17 USD 86.54
2024-11-01 (Friday)128,915USD 11,156,304ITCI holding increased by 230758USD 11,156,3040USD 230,758 USD 86.54 USD 84.75
2024-10-31 (Thursday)128,915USD 10,925,546ITCI holding decreased by -92819USD 10,925,5460USD -92,819 USD 84.75 USD 85.47
2024-10-30 (Wednesday)128,915USD 11,018,365ITCI holding increased by 1124139USD 11,018,3650USD 1,124,139 USD 85.47 USD 76.75
2024-10-29 (Tuesday)128,915USD 9,894,226ITCI holding decreased by -9024USD 9,894,2260USD -9,024 USD 76.75 USD 76.82
2024-10-28 (Monday)128,915ITCI holding decreased by -451USD 9,903,250ITCI holding increased by 96014USD 9,903,250-451USD 96,014 USD 76.82 USD 75.81
2024-10-25 (Friday)129,366USD 9,807,236ITCI holding increased by 21992USD 9,807,2360USD 21,992 USD 75.81 USD 75.64
2024-10-24 (Thursday)129,366USD 9,785,244ITCI holding increased by 80207USD 9,785,2440USD 80,207 USD 75.64 USD 75.02
2024-10-23 (Wednesday)129,366USD 9,705,037ITCI holding decreased by -267788USD 9,705,0370USD -267,788 USD 75.02 USD 77.09
2024-10-22 (Tuesday)129,366USD 9,972,825ITCI holding increased by 23286USD 9,972,8250USD 23,286 USD 77.09 USD 76.91
2024-10-21 (Monday)129,366USD 9,949,539ITCI holding decreased by -184993USD 9,949,5390USD -184,993 USD 76.91 USD 78.34
2024-10-18 (Friday)129,366USD 10,134,532USD 10,134,532
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of ITCI by Blackrock for IE00BYZK4776

Show aggregate share trades of ITCI

DateActionQuantityMarket HighMarket LowLikely Trade PriceLikely Trade Value (Profit/Loss)Average Price previous trades
2025-03-31SELL-924 131.920* 109.96 Profit of 101,600 on sale
2025-03-21SELL-924 131.650* 108.24 Profit of 100,013 on sale
2025-03-12SELL-462 131.250* 105.89 Profit of 48,920 on sale
2025-02-28SELL-462 128.200* 102.61 Profit of 47,407 on sale
2025-02-25BUY462 128.580* 101.28
2025-02-20SELL-462 128.540* 99.79 Profit of 46,103 on sale
2025-02-19BUY924 128.600* 99.26
2025-02-18BUY462 127.960* 98.71
2024-12-30BUY1,112 83.480* 84.02
2024-12-06SELL-454 84.550* 84.01 Profit of 38,139 on sale
2024-12-04SELL-454 85.950* 83.93 Profit of 38,106 on sale
2024-12-03SELL-908 85.310* 83.88 Profit of 76,165 on sale
2024-11-22BUY972 85.690* 83.14
2024-11-21SELL-452 85.450* 83.02 Profit of 37,526 on sale
2024-11-20SELL-454 85.640* 82.88 Profit of 37,626 on sale
2024-11-19SELL-454 83.350* 82.85 Profit of 37,613 on sale
2024-11-18SELL-1,804 82.470* 82.87 Profit of 149,500 on sale
2024-11-12SELL-451 88.490* 82.50 Profit of 37,206 on sale
2024-11-07SELL-451 90.510* 81.20 Profit of 36,623 on sale
2024-11-05SELL-902 89.240* 79.72 Profit of 71,912 on sale
2024-10-28SELL-451 76.820* 76.09 Profit of 34,318 on sale
Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of ITCI

DateShorted VolumeShort Exempt VolumeTotal Shares Traded% Shorted
2025-04-01773,0583991,138,87667.9%
2025-03-31181,469296556,14332.6%
2025-03-28121,14410,518391,18331.0%
2025-03-2761,81611,255411,76915.0%
2025-03-2644,818201289,31715.5%
2025-03-2573,685100355,58820.7%
2025-03-2441,9465125,56733.4%
2025-03-21136,2370449,38430.3%
2025-03-20223,583750364,72361.3%
2025-03-1929,88849530,9085.6%
2025-03-1819,755240223,6078.8%
2025-03-1753,9060222,81424.2%
2025-03-1493,1881279,86033.3%
2025-03-1371,56027,820532,17313.4%
2025-03-12300,615213,144782,62838.4%
2025-03-11632,677526,837815,39877.6%
2025-03-10249,47315,501919,98427.1%
2025-03-0769,84734310,44922.5%
2025-03-0643,928852315,35213.9%
2025-03-05307,86471,442,75821.3%
2025-03-04114,301162893,50512.8%
2025-03-03399,3721,4072,726,26714.6%
2025-02-2862,876869413,83715.2%
2025-02-27117,61328,149569,07420.7%
2025-02-26160,3410839,63819.1%
2025-02-25113,859168801,48714.2%
2025-02-24108,7281,403668,72716.3%
2025-02-2175,760200478,19515.8%
2025-02-2054,3860647,9188.4%
2025-02-19166,2319381,106,36315.0%
2025-02-1882,2809,143630,65413.0%
2025-02-14113,9742,172411,69927.7%
2025-02-1375,4485,925451,98116.7%
2025-02-12119,8984,194463,85825.8%
2025-02-11145,52120564,85625.8%
2025-02-10138,6330340,24340.7%
2025-02-0784,1908,470281,91329.9%
2025-02-06156,7138844,59018.6%
2025-02-05231,56930941,63824.6%
2025-02-04163,624471,769,5199.2%
2025-02-03172,1533,154551,65531.2%
2025-01-3149,100675559,3968.8%
2025-01-3066,539301,124,8075.9%
2025-01-29171,7924,5411,295,19313.3%
2025-01-2857,0914311,158,7674.9%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.